A pilot study: effect of irisin on trabecular bone in a streptozotocin-induced animal model of type 1 diabetic osteopathy utilizing a micro-CT
Background Osteoporosis is a significant co-morbidity of type 1 diabetes mellitus (DM1) leading to increased fracture risk. Exercise-induced hormone ‘irisin’ in low dosage has been shown to have a beneficial effect on bone metabolism by increasing osteoblast differentiation and reducing osteoclast m...
Main Authors: | Sahar Mohsin, Fiona Brock, Suneesh Kaimala, Charlene Greenwood, Mohsin Sulaiman, Keith Rogers, Ernest Adeghate |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-10-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/16278.pdf |
Similar Items
-
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects
by: Graziana Colaianni, et al.
Published: (2019-05-01) -
Role of irisin in bone diseases
by: Ruobing Zhao, et al.
Published: (2023-08-01) -
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
by: Guarnotta V, et al.
Published: (2020-05-01) -
TRABECULAR BONE SCORE AND DENTAL IMPLANT
by: Dan Pereţianu, et al.
Published: (2018-09-01) -
Role of Irisin in Endocrine and Metabolic Disorders—Possible New Therapeutic Agent?
by: Letitia Leustean, et al.
Published: (2021-06-01)